Thermo Fisher Scientific Inc. (NYSE:TMO) is one of Goldman Sachs’ top healthcare stock picks. On June 25, the company ...

Fisher Thermo Scientific shares tumbled to a more than three-year low as sales missed estimates and the company cut its guidance.

Thermo Fisher's core pharma, biotech, and bioproduction businesses are driving growth. Click here to read why TMO stock is a ...

Thermo Fisher Scientific would acquire Olink Holding AB in a deal valued at $3.1 billion, the companies said on Tuesday, as the U.S. medical equipment maker seeks to boost its life sciences ...

(Reuters) -Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing ...

In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

Thermo Fisher to cut 300 jobs in Cambridge, Plainville By Dana Gerber Globe Staff,Updated February 3, 2025, 12:46 p.m.

Conclusion Thermo Fisher was priced for perfection in January near $600, and we got a lot of imperfection in the form of slow growth plus tariff and fiscal policy headwinds.

Thermo Fisher's profit margin is also higher now than it was then. So yes, Thermo Fisher is still very much worth buying. Its stock may still decline a bit in the near term as the economy sputters.

The family of Henrietta Lacks, a Black woman whose cells have been used for scientific research for decades, reached a settlement Tuesday with the biotech company Thermo Fisher Scientific, the ...

The lawsuit demanded the family be paid for the company's use of Henrietta Lacks' cells, which were taken without consent in the 1950s and used in research.